UBS Group’s WisdomTree True Emerging Markets Fund XC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9
Closed -$281 11107
2026
Q1
$281 Sell
9
-99
-92% -$3.26K ﹤0.01% 9980
2025
Q4
$3.5K Sell
108
-1,234
-92% -$42.6K ﹤0.01% 9005
2025
Q3
$46.5K Sell
1,342
-150
-10% -$5.15K ﹤0.01% 7618
2025
Q2
$51.4K Buy
+1,492
New +$47K ﹤0.01% 7746
2023
Q4
Sell
-985
Closed -$25.8K 9952
2023
Q3
$25.8K Buy
+985
New +$27.2K ﹤0.01% 6674
2023
Q1
Sell
-849
Closed -$21K 10474
2022
Q4
$21K Buy
+849
New +$20.9K ﹤0.01% 7592

Other funds holding XC

UBS Group's XC Position: Q2 2026 in Review

UBS Group sold out of WisdomTree True Emerging Markets Fund (XC) in Q2 2026, closing a stake of 9 shares — an estimated $281 sold.

UBS Group first reported a position in XC in Q4 2022 and held it in 6 quarters. The position peaked at $51.4K in Q2 2025. 29 funds tracked by Wall St. Rank hold XC as of Q2 2026.

  • UBS Group reported no remaining WisdomTree True Emerging Markets Fund position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 9 WisdomTree True Emerging Markets Fund shares in Q2 2026, an estimated $281.
  • UBS Group first reported a position in WisdomTree True Emerging Markets Fund in Q4 2022 and held it in 6 quarters.
  • UBS Group's WisdomTree True Emerging Markets Fund position peaked at $51.4K in Q2 2025.
  • 29 funds tracked by Wall St. Rank held WisdomTree True Emerging Markets Fund as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.